Gut mucin fucosylation dictates the entry of botulinum toxin complexes.

bioRxiv : the preprint server for biology 2025

Amatsu S, Matsumura T, Morimoto C, Keisham S, Goto Y, Kohda T, Hirabayashi J, Kitadokoro K, Katayama T, Kiyono H, Tateno H, Zuka M, Fujinaga Y

관련 도메인

Abstract

Botulinum toxins (BoNTs) are the most potent known bacterial toxins. The BoNT complex from B-Okra (large progenitor toxin complex (L-PTC)/B, hyper-oral-toxic) exerts at least 80-fold higher oral toxicity in mice compared with that from serotype A1 (L-PTC/A, non-hyper-oral-toxic). Here, we showed that L-PTC/B was predominantly absorbed through enterocytes, whereas L-PTC/A targeted intestinal microfold cells. Furthermore, we demonstrated that α1,2-fucosylation of intestinal mucin determined the oral toxicity of L-PTCs as well as their entry routes; more specifically, these routes were governed by the carbohydrate-binding spectrum of hemagglutinin (HA) complex, which is one of the L-PTC components. Disruption of fucosylation in fucosyltrasferase-2 ()-null mice hindered the intestinal mucin penetration of L-PTC/B via HA and reduced the susceptibility to its oral intoxication. Our data establish the molecular mechanism by which the oral toxicity of BoNTs is increased after they cross intestinal mucus layers.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
재료 ha 히알루론산 dict 2
시술 botulinum toxin 보툴리눔독소 주사 dict 1
해부 Gut mucin scispacy 1
해부 large progenitor toxin scispacy 1
해부 oral scispacy 1
해부 enterocytes scispacy 1
해부 intestinal microfold cells scispacy 1
약물 BoNTs → Botulinum toxins C0006055
Botulinum Toxins
scispacy 1
약물 fucosyltrasferase-2 scispacy 1
약물 L-PTC/B scispacy 1
약물 L-PTCs scispacy 1
질환 toxicity C0040539
Toxicity aspects
scispacy 1
질환 non-hyper-oral-toxic scispacy 1
질환 intestinal mucin scispacy 1
질환 intestinal mucus layers scispacy 1
기타 mice scispacy 1
기타 serotype A1 scispacy 1
기타 hemagglutinin scispacy 1
기타 BoNTs → Botulinum toxins scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문